POPULARITY
Categories
This week on the KORE Women podcast, Dr. Summer Watson is joined by Janelle Miller Moravek, Executive Director of Youth and Family Counseling and a dedicated mental health advocate, who has spent over a decade expanding access to care in her community. In this conversation, we talk about the realities of leading in the nonprofit sector, what it takes to sustain impact over time, and the challenges that continue to limit access to mental health services. Janelle shares insight into the growing shortage of mental health professionals, why so many individuals still struggle to access care, and what needs to change to better support communities. If you care about mental health, leadership, and creating meaningful impact, this episode offers both perspective and direction. You can connect with Janelle Miller Moravek at: Website: CounselingForAll.org/ LinkedIn: Linkedin.com/in/janelle-miller-moravek-903a815b/ Janelle's profile: accessspeakers.biz/speaker/janelle-miller-moravek-nonprofit-leader-mental-health-advocate/ Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomen #MentalHealthAwareness #NonprofitLeadership #CommunityImpact
On this episode, we travel beyond the northeast to examine South Carolina in the Revolutionary War. We examine the Siege of Charleston and compare the town's experience to that of Boston. Note that, although American forces besieged British troops in Boston, at Charleston, those roles were reversed and American forced held the city against an ultimately victorious British army. We also discuss the significance of Henry Laurens, a founding father from South Carolina who was highly regarded by John Adams. We are joined by Elizabeth Chew, CEO of the South Carolina Historical Society, and Greg Brooking, author and historian of the American Revolution in the South. At the MHS, we examine several items related to the Revolution in South Carolina and are joined by a special guest. Reference Librarian Daniel Hinchen also reprises his role as John Adams. This episode was produced in collaboration with From the Vault: The SCHS Podcast. We encourage you to listen to their upcoming episode highlighting the relationship between two founding fathers: John Adams and Henry Laurens. Learn more here. Learn more about episode objects here: https://www.masshist.org/podcast/season-5-episode-6-South-Carolina Email us at podcast@masshist.org. Episode Special Guests: Dr. Elizabeth Chew became CEO of the South Carolina Historical Society in January 2024. A public historian, curator, and educator, she has worked at museums and history organizations for over thirty years. Prior to arriving in Charleston, she served as Executive Vice President and Chief Curator at James Madison's Montpelier in Orange, Virginia and as Curator at Thomas Jefferson's Monticello in Charlottesville. She received a BA from Yale University, an MA from the University of London, and a Ph.D. from UNC- Chapel Hill. Dr. Brooking is high school teacher in Fulton County, GA and the author of From Empire to Revolution: Sir James Wright and the Price of Loyalty in Georgia. Daniel Hinchen is a Reference Librarian at the Massachusetts Historical Society. This episode uses materials from: Cloudbank by Podington Bear (Attribution-NonCommercial 3.0 Unported) Psychic by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk) Curious Nature by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk)
Today, Sam tries to convince you all to play MHS 3! Also, DJ is filming on location for this episode and forgot to bring his podcast equipment, so he sometimes sounds like he is under water - fun!
This week on the KORE Women podcast, Dr. Summer Watson is joined by Amrita Mukherjee, who is a global speaker, executive coach, author, and founder of SHEvolution, whose work helps women build careers and lives defined by purpose, confidence, and impact. Her journey into leadership was shaped by early life challenges and personal loss, experiences that deepened her emotional awareness and resilience. We explore what it truly means to lead with emotional intelligence and how women can move from silent potential to visible impact. We also touch on her fiction novels, Avani The Girl Who Found Her Voice: A Story of Finding Strength, Love and A Lost Dream and She & Me, where storytelling becomes a powerful extension of her work. If you're ready to lead with more clarity and intention, this episode is for you. You can connect with Amrita Mukherjee on LinkedIn, Instagram and at: thrivingwomenstribe.com and you can also find her books on Amazon. LinkedIn: https://www.linkedin.com/in/mukherjeeamrita/ Instagram: https://www.instagram.com/iamamritamukherjee Links to her books: Avani The Girl Who Found Her Voice - https://amzn.in/d/056QnH4n She & Me - https://amzn.in/d/0a0WLRP Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomen #EmotionalIntelligence #WomenInLeadership #Resilience
Become the Medetomi-Dean of AdmissionsStep up your hospital addiction medicine game by learning to troubleshoot methadone dose confirmations/missed doses and understanding how medetomidine's emergency in the drug supply is impacting patients and withdrawal management. We're joined by Dr Maggie Lowenstein (University of Pennsylvania)Claim CME for this episode at curbsiders.vcuhealth.org!By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME!Credits Writer, Producer, and Show Notes: Shawn Cohen MD Infographic and Cover Art: Zoya Surani Hosts: Carolyn Chan, MD. MHS and Shawn Cohen MD Reviewer: Payel Jhoom Roy MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Maggie Lowenstein MD MPhil MSHP Sponsor: BabbelGo to Babbel.com/CURB for up to 60% off.Sponsor: FIGSCurbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.Sponsor: FreedSetup takes 30 minutes and pricing starts at $149 a month. Try it free for 7 days at getfreed.ai/front-desk.
Cyanotic congenital heart diseases occur in approximately 0.2% of live births in the US, but survival to adulthood is common with current surgical interventions. JAMA Associate Editor David Simel, MD, MHS, speaks with author Michael Landzberg, MD, who coauthored a recent review in JAMA on this topic. Related Content: Survivors of Cyanotic Congenital Heart Disease
Harvard Professor Dr. JoAnn Manson reveals the final results of the VITAL trial: a landmark study on Vitamin D, telomeres, and disease prevention.Is Vitamin D the most underrated molecule in longevity science? Dr. JoAnn Manson, Professor of Medicine at Harvard Medical School and lead investigator of the massive VITAL trial, joins us to present groundbreaking new data. We move past the traditional focus on bone health to explore how 2,000 IU of Vitamin D preserves telomere length, effectively slowing biological aging by three years. Dr. Manson discusses the 22% reduction in autoimmune diseases and the 17% reduction in advanced metastatic cancers found within the 25,000-participant study. We also tackle the "BMI Gap", the critical reason why Vitamin D benefits are often blunted in certain populations, and the importance of the Vitamin D/Omega-3 synergy. This conversation provides a definitive clinical roadmap for anyone using these supplements to extend their healthspan. Rooted in gold-standard randomized controlled trial data, this is an essential update on the science of aging well.MEDICAL DISCLAIMER: Modern Healthspan provides reports on peer-reviewed longevity research. We do not provide medical advice, diagnosis, or treatment. The clinical findings presented by Dr. JoAnn Manson from the VITAL trial are for informational use only. Please see your physician before starting 2,000 IU of Vitamin D or any other supplement protocol.
In this episode, Lyell K. Jones Jr, MD, FAAN, speaks with Cheryl Bushnell, MD, MHS, who served as the guest editor of the June 2026 Cerebrovascular Disease issue. They provide a preview of the issue, which publishes on June 3, 2026. Dr. Jones is the editor-in-chief of Continuum: Lifelong Learning in Neurology® and is a professor of neurology at Mayo Clinic in Rochester, Minnesota. Dr. Bushnell is a Professor of Neurology and Director of the Center for Transformative Stroke Care at Wake Forest University School of Medicine in Winston-Salem, North Carolina. Additional Resources Read the issue: continuum.aan.com Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @LyellJ Guest: @CBushnellMD Full episode transcript available here Dr Jones: One of the core tenets of our field is that we learn neurology one stroke at a time. But what do we have to learn about preventing them altogether? The science of stroke prevention, acute treatment, and recovery are evolving rapidly, and it's hard to keep up. Today, we're speaking with Dr. Cheryl Bushnell, guest editor of our latest Continuum issue on Cerebrovascular Disease, to discuss these topics and much more. Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast. Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum: Lifelong Learning in Neurology. Today, I'm interviewing Dr. Cheryl Bushnell, who is Continuum's guest editor for our latest issue on Cerebrovascular Disease. Dr. Bushnell is a professor of neurology and the director of the Center for Transformative Stroke Care at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where she specializes in the care of stroke patients and their social and functional determinants of recovery and health, and is an internationally recognized expert on those topics. Dr. Bushnell, welcome. Thank you for joining us today. Why don't you introduce yourself to our listeners? Dr Bushnell: Absolutely. Thank you for the invitation. It's really an honor to be here. So, as you mentioned, I am the director of the Center for Transformative Stroke Care at Wake Forest. It's a really fun transition for me to be involved with different care models for stroke, and I think a lot of the Continuum topics are directly relevant to some of the things that I'm doing now as an administrator and sort of a facilitator of new research. So, thanks again for having me. Dr Jones: Yeah, and, and you have a wonderful perspective, and we're gonna pull that out today in our interview questions, and I'm looking forward to sharing that with our listeners. But before we get to the questions, we're gonna start off today's podcast with another Continuum Audio trivia question for our listeners. Anticoagulation has played a critical role in secondary ischemic stroke prevention for a long time now. While direct oral anticoagulants have taken on a greater role in the treatment of prevention of stroke, there are still some use cases for vitamin K antagonists like warfarin. The trivia question for our listeners is this: How was warfarin discovered, and how did it get its name? Stick around and we'll share the answer to that question toward the end of our interview today. So, Dr. Bushnell, let's get right to it. You alluded to your various roles, and your leadership in the field has been exemplary. The interventions for acute ischemic stroke have really exploded over the last decade or so, and they get a lot of attention and discussion, but prevention and recovery are just as important in the care of these patients. Tell us a little more about how you approached this issue, about the article topics you chose, etc. Dr Bushnell: Well, once I was chosen to lead the guest editorship, I wanted to come up with a group of topics that were maybe a little bit different from previous issues. So, I kind of looked at the previous issues and saw, as you said, an emphasis on acute stroke, and that's really important because it has been evolving. But my thought was, how about what happens to patients after they get the intervention and they're discharged home? And because a lot of trainees may not get to see these patients ever again, or it's months before they might see them, or if they're readmitted, which is what we don't want to see, but that certainly is a lot of the exposure is in the inpatient setting. So, I thought I would kind of transport the education into the outpatient and transitional setting, as well as prevention, not only secondary, but primary prevention, with an emphasis on brain health. Some of the populations that may not get as much attention. So, sex differences, stroke in women, pregnancy, the transitions of care, and also the emphasis on holistic view of patients and their challenges, which includes the non-medical factors that drive health, otherwise known as social determinants of health. Dr Jones: I appreciate that perspective, and obviously th-this is an area of your deep expertise, and it's great to have an issue that really digs into some of those topics a little more deeply. As an educator, I'm really glad you mentioned that about the trainee's perspective. You know, especially junior neurology trainees that are in the hospital all the time. They're seeing patients in the middle of a cerebrovascular catastrophe. But there's a long tail of recovery, right? And they'll get to see that in continuity clinic, but it's a good message to share from an evidence and, um, experiential perspective in the issue. So, appreciate that perspective. You've just read all these articles and edited them. Was there anything that you ran across that was a surprise to you? Dr Bushnell: Well, I personally chose a lot of the authors based on my knowledge of their work. So, I wouldn't say that it was completely surprising, but I do think that I was just genuinely impressed with the quality of the writing and the synthesis of information. I just was incredibly proud of the work that these co-authors have put together. I'd say that that was-- it wasn't surprising so much as just a sense of pride that I had with the product that's coming out. But of course, there have been some new trials that had to be incorporated at the last minute, some of which were presented at the International Stroke Conference just a few weeks ago. Dr Jones: Yeah. We try to be as up-to-date as we can, and I will completely agree with you. We have some really good writers in our field, and it's really just a pleasure when you read an article that's by an expert, and it's a joy to read. I can tell you it's one of the best parts of this job, and you get to learn a lot. I think one of the more challenging scenarios that I hear about from colleagues in recent years has been optimal management of patients with asymptomatic extracranial atherosclerosis. The pivotal trials that inform how we manage those patients were from a long time ago, decades ago, predating a lot of the more intensive medical management tools that we have today. In that scenario, Dr. Bushnell, what's the latest on that, and what should our listeners know? Dr Bushnell: Well, obviously, the CREST 2 trial has been long awaited. It's been going on for over ten years, I believe. Of course, it's, uh, two different trials all in one, the carotid stenting and angioplasty versus intensive medical management. And of course, each of the carotid vascularization arms of the trial also had intensive medical management. And then the other trial is the carotid endarterectomy as the form of revascularization. And it interestingly did not show any benefit of carotid endarterectomy compared to intensive medical management. But of course, the somewhat surprising result was that carotid angioplasty and stenting truly was superior, although it was a small number of events in the trial overall. But that stenting plus intensive medical management was somewhat better than intensive medical management alone. And I think stenting has come a long way in terms of safety, and so I think that's been part of the evolution of the field. I do wanna say that I'm a huge fan of the intensive medical management, and I think that what the protocol does in terms of blood pressure management, cholesterol management is very much above and beyond what's done in private practice even. And the health coaching for all the other things related to diabetes and weight loss and smoking cessation and physical activity, that is what we need to be doing to actually decrease the risk of stroke, and I think that it's very effective. I can't say enough about the design of the study for that reason, that everyone gets the intensive medical management, and then you just layer on the type of revascularization on top of it. So, I wouldn't have been surprised if this was a completely negative trial overall. They just happened to have some better outcomes in the stenting arm. Dr Jones: I recall a few years ago when the series of endovascular therapy trials for acute stroke came out, and I think there was a, a period of time where the field had to adapt to that. I wonder what you think about with the CREST 2 findings on stenting. I mean, is that gonna be a big change? Because obviously atherosclerosis is highly prevalent. Is that gonna be a big change? Is the field ready for that? How much adjustment do we have in store? Dr Bushnell: I'm not sure it's gonna be a really big change. If you read the editorial that accompanied the trial in the New England Journal, just a few patients in either direction would have changed the outcome. I kind of look at it as an absolute difference that's relatively small. So, I'm not sure that it will have a huge impact on the field. I do think that the specialists who insert the stents may have some differences of opinion of who should be stented and who shouldn't. Because I think, you know, all of the specialists who do procedures were involved with the trial. But I would say there's a larger percentage of vascular surgeons who were involved, and so I'd say they may have a change of their practice. And neurologists may not even get involved at all. Dr Jones: Right. Dr Bushnell: That was one of the challenges for getting patients in the trial is that, you know, not all of us see the asymptomatic carotid stenosis, that they tend to get referred to vascular surgery. So, I think maybe in a corner of the practices of vascular surgeons is where you might see the differences. Dr Jones: Your point about the way the trial was designed or the trials were designed, that intensive medical management is really important, and we have huge gaps in that. In our specialty, it's, you know, we have probably an opportunity in primary care even to address that. And that leads me to my next question. You know, given your perspective and your expertise, what do you think is the biggest practice gap in the care of patients with stroke or with cerebrovascular disease of any kind? Dr Bushnell: I think by far the biggest gap is transitions of care and access to follow-up in a specialty clinic after discharge and continuous secondary prevention. We only call it secondary prevention because it happened to come after a stroke, but I really feel like we should just focus on prevention and call it that. There are a lot of people who are trying to kind of, get us away from primary versus secondary prevention. And, and Mitch Elkind is phenomenal and had a beautiful chapter weaving in prevention and brain health. So, I highly recommend that people, if they don't read any other chapters of the Continuum to read his, because I think that it's getting to your point about where the gaps are, and I think prevention is the biggest one. I think we could do so much more in models of care to ensure that there is a pathway once patients are discharged. We have no quality metrics. We have no measurement of how well people are doing after they're discharged. We have all of these fancy things and sophisticated acute treatments, but all of those are for naught if somebody goes home and they fall and they have a severe head injury or hip fracture because they weren't properly supervised or they didn't have the help that they needed at home. So, you got me on my soapbox here for a second, but that is definitely what I see as the gap. Dr Jones: That's an important soapbox, an important gap, and obviously, if it was a simple problem, we could solve it. But it's obviously something that education is a valuable tool for that, and that's part of why we are including so much content in this issue of Continuum. So, if we put that aside as a gap that we would love to close, when you look into the near future or distant future, Dr. Bushnell, and what's the next big thing on the horizon? New interventions, new prevention tools, or something else entirely? What do you think? Dr Bushnell: There are two things that I would mention. One is sort of the new category of anticoagulants, antithrombotics, the factor XIa inhibitors. We had an amazing presentation of the oceanic stroke trial at the International Stroke Conference, and this is probably going to be a game changer for the arsenal of antithrombotic therapies that we can offer to patients that do not have a reason for anticoagulation. So, they, they don't have atrial fibrillation, for example, or something else that requires anticoagulation. And so, the factor XI, asundexian, is the drug that they used in that trial. The safety profile is pretty amazing. There was very little bleeding complications and a great benefit in those patients with some degree of atherosclerosis, but, you know, of course, not enough to require carotid revascularization, but then also, um, small vessel disease and cryptogenic stroke. I think those are the three categories of patients, and that's a lot of the strokes that we see all benefited from this new drug. So, I think that's gonna be exciting. There, of course, it has to go through the FDA approval process, and so it might take a little bit of time before that's on the market, and we don't know how much it's gonna cost, but I think it is a, a major breakthrough. And of course, there are other similar medications in that category that are coming. And then I think the other thing is the emphasis on brain health and lifestyle factors and the things that we can do to prevent stroke and dementia because they are the same, essentially. Those are really important. And when we have someone in the hospital with a stroke or a TIA in particular, it's a great teaching opportunity for those patients to say, "Hey, here's what you can do to protect your brain." These are things that we always tell people to prevent a stroke, but just think about it as protecting your brain and keeping your brain as healthy as possible. Dr Jones: That's a great message, and one that you get to share with patients directly. You're joining us today for this interview. You're on stroke service, so you're actively involved in caring for patients with stroke. What in your practice is the most rewarding aspect of caring for these patients? What is it that you find most rewarding? Dr Bushnell: I've been involved in a clinical trial that has focused on managing blood pressure and also coaching and other aspects of stroke recovery. I think that has probably been the most rewarding aspect of my career. Until I was involved with this trial, I didn't necessarily do intensive blood pressure monitoring, but I'm seeing the benefits of having data from home, what those blood pressures are over a span of time. I see the immediate or intermediate effects of the blood pressure medication changes that I've made, and I see how the patients respond. So, I have to say that this is not part of usual practice, but I think it should be. And I think it's been incredible from the perspective of a neurologist who is really intensively trying to make the patients' lives better. And it's not just what I do, it's what the health coaches do as part of this intervention. And again, very similar to intensive medical management. So, I, I feel like I've been living it in a slightly different setting than in the CREST 2 trials. But there are other trials that have used the intensive medical management as approach as well. But I would say that's the most rewarding. I've seen people who've lost weight, who are physically fit, who are able to get off of blood pressure medications practically by the end of six months, and that's amazing. And then they continue doing it because they see the benefits. Dr Jones: You've had a front row seat to a lot of that. That's really got to feel rewarding. Dr Bushnell: It is, absolutely. Dr Jones: You know, when you put it that way, it makes me want to go home and check my blood pressure, which I haven't done in a while. But I think that's a message to all of our listeners that we do have plenty of opportunity for risk factor optimization and following the evidence that has been generated and is being generated. Huge opportunity, not only at the population level, but I think the, um, individual patient level too. Okay, so now we're back to our Continuum Audio trivia question, and I'll repeat it for our listeners. How was warfarin discovered, and how did it get its name? Dr. Bushnell and I were talking about this earlier, so I'll just go ahead and share the answer. So, in the early 20th century in the U.S. Midwest, there were epidemics of a hemorrhagic disease in cattle, of all places, and this was eventually traced to moldy cattle feed that was made from sweet clover. And in 1940, researchers at the University of Wisconsin discovered that the anticoagulant in the sweet clover was a compound that was later synthesized for therapeutic use in 1954 as warfarin. And the name came from, uh, the support for the research. The research support came from the Wisconsin Alumni Research Foundation, or WARF, and the end of the word came from the underlying compound, which was coumarin. So that was a little bit of trivia that I had never heard. It's not in the issue, everyone, so you're getting something extra here on the podcast. But been using the drug forever. It still has its uses, even though it's become less advantageous than some of the newer agents. But-- And of course, Dr. Bushnell already knew that when I brought it up, but I just thought that was an interesting bit of history. Well, Dr. Bushnell, thank you for joining us. Thank you for such a great conversation about the latest in cerebrovascular disease. I learned a lot today. I learned a lot in reading these wonderful articles. I hope our listeners learned a lot today as well. I'm really grateful for your hard work on the issue, which I think will come in handy for junior readers and subscribers, as well as our more experienced neurologists as well. Sometimes it's hard to keep up with a rapidly changing subspecialty of our field. So, thank you for joining us today. Dr Bushnell: Thank you for having me. It's been my pleasure. Dr Jones: Again, today we've been speaking with Dr. Cheryl Bushnell, guest editor of Continuum's most recent issue on cerebrovascular disease. Please check it out, and thank you to our listeners for joining today. Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.
This week on the KORE Women podcast, Dr. Summer Watson is joined by Jill Margaret Shulman, who is a college admissions expert, author, and founder of In Other Words, a college essay coaching service, who has evaluated thousands of applications for top colleges. In this conversation, we break down what really matters when it comes to the college essay and how students can approach the process with more confidence and less stress. Jill shares what admissions readers are actually looking for, why the pressure to be “perfect” often gets in the way, and how students can find their voice even if they don't think they have a standout story. We also talk about overcoming quieting self-doubt and navigating this process in a way that feels authentic and manageable. If you or someone you know is preparing to write college applications, this episode offers clarity, reassurance, and practical guidance. You can connect with Jill Margaret Shulman at: Instagram: https://www.instagram.com/jill.shulman Facebook: https://www.facebook.com/jill.shulman.5 LinkedIn: https://www.linkedin.com/in/jillmargaretshulman http://www.JillShulman.com (You can find free worksheets and informationals on her website) Jill's product page on Amazon: https://a.co/d/36A6D1n. Jill's Book on Amazon: https://www.amazon.com/College-Essay-Confidence-Knockout-Application/dp/1955831068 Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomen #CollegeAdmissions #CollegeEssay #StudentSuccess
In part two of this conversation, host Emma Sellers, MS, continues her discussion with Lucy Kibe, DrPH, MS, MHS, PA-C, co-founder of AmKeny, a nonprofit organization connecting U.S. physician associates and clinicians with Kenyan clinical officers to support healthcare, education, and community initiatives in Kenya. Joining the conversation are Laye Akinloye, PA-C, Emeritus; Alabi Akinloye, PA; Miriam Ha, PA; and pre-PA students Gaelen Waar and Ajana Williams, who reflect on their experiences participating in AmKeny's medical outreach work in Kitale, Kenya. The group discusses the global role of physician associates and similar professions such as Kenya's clinical officers, highlighting the impact of collaborative, community-centered care. Miriam and the clinicians share lessons learned through service, listening, and cultural exchange, while Gaelen and Ajana describe transformative moments working alongside healthcare teams, including helping connect dozens of patients to free cataract surgeries through an eye clinic initiative. The episode also explores the importance of teamwork, cultural communication, and sustainable support efforts, as Lucy shares AmKeny's plans for future outreach trips and encourages support through local supply purchases and donations. Along the way, the guests reflect on the relationships built through the experience, as well as the opportunity to explore Kenya's culture, communities, and landscapes. This episode is sponsored by Lincoln Memorial University School of Medical Sciences. For more information about the doctor of medical science program, visit https://www.lmunet.edu/school-of-medical-sciences/dms/. For more information on the medical education major curriculum, visit https://www.lmunet.edu/school-of-medical-sciences/dms/medical-education-major-curriculum. The PA Path Podcast is produced by Association Briefings.
onis Pengadilan Militer Tinggi I Medan untuk Sersan Satu Riza Pahlivi dalam kasus kematian seorang pelajar SMP inisial MHS di Medan, Sumatera Utara menuai sorotan. Vonis juga tidak menjatuhkan sanksi pemecatan terhadap Rizs Pahlivi yang diduga melakukan penganiayaan saat membubarkan tawuran pada 24 Mei 2024 lalu. Korban yang saat itu hanya melintas di lokasi tawuran sempat ditangkap dan diduga mengalami penganiayaan di sejumlah bagian tubuhnya sehingga korban meninggal dunia. Bagaimana menanggapi vonis tersebut? talk Pakar Hukum Pidana Abdul Fickar Hadjar
Welcome back to Morgan Hasn't Seen with Jeannine Brice & Morgan Robinson!!Battling extraterrestrial forces and defending planet earth on MHS throughout May as Jeannine has curated a fascinating variety of ALIEN INVASION movies for this series!The most recent movie in the long running Alien franchise closes out this series as we bookend with horror with a return to critical acclaim for the franchise as Jeannine and Morgan talk David Jonsson & Cailee Spaeny in ALIEN: ROMULUS!Our YouTube Channel for all our regular videos: https://www.youtube.com/channel/UCvACMX8jX1qQ5ClrGW53vowDonate: https://www.buymeacoffee.com/ItsAWonderful1Join our Patreon: https://www.patreon.com/ItsAWonderful1IT'S A WONDERFUL PODCAST STORE: https://www.teepublic.com/user/g9designSub to the feed and download now on all major podcast platforms and be sure to rate, review and SHARE AROUND!!Keep up with us on (X) Twitter:Podcast: https://twitter.com/ItsAWonderful1Morgan: https://twitter.com/Th3PurpleDonJeannine: https://twitter.com/JeannineDaBean_Keep being wonderful!!
This week on The KORE Women podcast, Dr. Summer Watson welcomes Mandy Tang, who is a career coach, holistic healer, and author of “Heal Your Career Wounds: Navigating the Trauma of Today's Workplace.” Mandy brings a powerful and much-needed perspective to the conversation around work, burnout, and identity. We talk about how workplace experiences can leave lasting emotional impact, why high achievers are often the most quietly affected, and how hustle culture has trained many of us to ignore what we're actually feeling. Mandy shares how burnout develops, what happens when our sense of worth becomes tied to achievement, and what it looks like to rebuild a healthier, more grounded relationship with your career. If you've ever felt successful on the outside, but unsettled on the inside, this episode will resonate deeply and offer a new way forward. You can connect with Mandy Tang on LinkedIn and on TikTok, Instagram, and YouTube at: CareerCoachMandy and at: www.mandytang.co. You can also find her book on Amazon Link to Mandy's book on Amazon: https://www.amazon.com/Heal-Your-Career-Wounds-Navigating/dp/1608689905 Mandy's social media links: TikTok (160K) - https://www.tiktok.com/@careercoachmandy Instagram: https://www.instagram.com/careercoachmandy/ YouTube: https://www.youtube.com/@careercoachmandy LinkedIn: https://www.linkedin.com/in/mandytang/ Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomen #CareerHealing #BurnoutRecovery #WorkplaceWellbeing
The "Community Meets Clinic" podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode hosted by Krissy Dilger of SRNA, we met Dr. Benjamin Greenberg of the UT Southwestern Medical Center. He outlined his translational research, including the Q Study, a Phase 1 trial assessing the safety and feasibility of transplanting human glial restricted progenitor cells into the spinal cord of people who have been diagnosed with transverse myelitis (TM) [05:49]. He also described research on immune-remodeling therapies for NMO aimed at reducing long-term immunosuppression. Dr. Greenberg illustrated multidisciplinary care at UT Southwestern and Children's Medical Center, emphasized options for second opinions and clinician-to-clinician remote consultation, and shared hopes for nervous system repair trials and curative immune therapies [07:18]. You can view Dr. Benjamin Greenberg's medical profile here:https://utswmed.org/doctors/benjamin-greenberg/Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome and Guest Intro01:41 Path to Neurology03:50 Why Neuroimmunology05:49 Research Focus and Trials07:18 Clinic Team and Referrals10:31 Self Care and Hobbies12:17 How the Clinic Can Help14:16 Hope for Future Therapies15:56 Wrap Up
Discover how the "Brain Energy Gap" drives cognitive decline and how ketones can rescue starving neurons. Dr. Stephen Cunnane explains the science of metabolic health, the BENEFIC trial, and how to fuel a hybrid brain for long-term longevity.Is Alzheimer's actually a fuel shortage in the brain? In this interview, world-renowned researcher Dr. Stephen Cunnane breaks down the "Brain Energy Gap", a critical metabolic deficit where the brain loses its ability to utilize glucose efficiently as we age. While this energy gap can lead to Mild Cognitive Impairment (MCI) and Alzheimer's, Dr. Cunnane's groundbreaking research, including the landmark BENEFIC trial, shows that ketones can bypass this blockage to provide a vital backup fuel source.We dive deep into the hybrid brain concept, exploring how Medium Chain Triglycerides (MCTs) and specific dietary shifts can "rescue" cognitive function by doubling brain ketone uptake. Dr. Cunnane also discusses the "double jeopardy" of insulin resistance and why managing metabolic health is the most promising frontier for preventing neurodegeneration. Whether you are interested in brain health, longevity, or the clinical applications of ketogenic metabolic therapy, this technical deep dive offers essential insights into the future of healthy aging
Welcome back to Morgan Hasn't Seen with Jeannine Brice & Morgan Robinson!!Battling extraterrestrial forces and defending planet earth on MHS throughout May as Jeannine has curated a fascinating variety of ALIEN INVASION movies for this series!Paul Verhoeven's bitingly satirical, hyper political, camp cult classic is up this week for Jeannine and Morgan to delve deep into as they talk all there is to talk about STARSHIP TROOPERS (1997) starring Casper Van Dien, Denise Richards & Dina Meyer!Our YouTube Channel for all our regular videos: https://www.youtube.com/channel/UCvACMX8jX1qQ5ClrGW53vowDonate: https://www.buymeacoffee.com/ItsAWonderful1Join our Patreon: https://www.patreon.com/ItsAWonderful1IT'S A WONDERFUL PODCAST STORE: https://www.teepublic.com/user/g9designSub to the feed and download now on all major podcast platforms and be sure to rate, review and SHARE AROUND!!Keep up with us on (X) Twitter:Podcast: https://twitter.com/ItsAWonderful1Morgan: https://twitter.com/Th3PurpleDonJeannine: https://twitter.com/JeannineDaBean_Keep being wonderful!!
This week on The KORE Women podcast, Dr. Summer Watson welcomes Mari-Liis Vaher, who is a global marketing strategist, entrepreneur, author of "The Greatest Marketer," and founder of the global platform supporting marketers and leaders, called “Powerful Marketers.” Mari-Liis brings a powerful perspective shaped by resilience, leadership, and real-world business experience. In this conversation, we explore why so many CEOs don't trust their marketing teams, how to bridge that gap with clarity and alignment, and what it truly takes to build sustainable marketing systems that actually deliver results. She also shares her journey of overcoming what once felt impossible and how her incredible resiliency continues to shape the way she leads, builds, and mentors others today. If you're a leader, marketer, or entrepreneur, who wants your work to create real impact without burning out, this episode will challenge and inspire you. You can connect with Mari-Liis Vaher on LinkedIn, at: Powerful-Marketers.com and find her book at: TheGreatestMarketer.Com LinkedIn: https://www.linkedin.com/in/vahermariliis/ Website: https://powerful-marketers.com/ Book Page: https://thegreatestmarketer.com/ Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #MarketingLeadership #MarketingStrategy #SustainableSuccess
Krissy Dilger of SRNA hosted Dr. Benjamin Greenberg of UT Southwestern to share updates on the Q Study, a Phase 1 trial assessing the safety and feasibility of transplanting human glial restricted progenitor cells into the spinal cord of people who have been diagnosed with transverse myelitis (TM). Dr. Greenberg cautioned the audience against stem cell tourism [00:03:03]. He described the decades-long development of the cell line and safety monitoring for this study [00:01:35]. He reported no safety signals prompting a trial pause and noted the FDA-approved expansion of eligibility from non-ambulatory participants to those who can walk with assistance, while efficacy results were not yet being shared [00:08:31]. Finally, Dr. Greenberg outlined potential next steps, including Phase 2 studies and expanded populations (e.g., MOGAD and NMOSD diagnoses), as well as future targets [00:17:02].Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [https://utswmed.org/why-utsw/departments/neurology/] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome and Guest Intro01:35 Origins of Q Study02:46 Getting Cells Into Cord04:49 Phase One Trial Design06:31 Safety and Efficacy Measures08:31 Eligibility Expanded Criteria11:39 Screening and Selection14:05 Travel and Site Logistics15:15 Early Safety Findings17:02 Next Steps After Phase One19:01 Beyond Idiopathic Myelitis23:07 Damage Differences by Disease25:20 Optic Nerve and Brain Targets27:29 Expected Outcomes and Vision28:58 Final Thanks
Muscle scientist Dr Brad Schoenfeld on how to stay strong after 60.Dr Brad Schoenfeld is a professor of exercise science at Lehman College, New York, and one of the world's most cited researchers on muscle hypertrophy. In this interview we cover the practical science of building and maintaining muscle as you age with a focus on what actually matters for healthspan and independence.We discuss how much training older adults really need, why power matters more than strength for fall prevention, and how to think about loads and reps after 60. Brad also explains why protein requirements increase with age, what the leucine threshold is and why it matters, and gives his frank assessment of the supplement landscape including the one he thinks has genuine evidence behind it.We also touch on VO2 max, balance, flexibility and the role of consistency. A practical, evidence-based conversation for anyone serious about staying strong and independent as they age.
This is the final episode of a three-part look at the geography, characters, and events that shaped the first years of the American Revolution. In looking at the American Invasion of Canada (1775-1776) we are joined by Luc Nicole-Labrie, the Senior History Advisor at the National Battlefields Commission in Québec. Back at the MHS, we also examine a few items from the collections that shed light on the difficulties of this endeavor to make Québec the fourteenth colony in rebellion. Learn more about episode objects here: https://www.masshist.org/podcast/season-5-episode-5-Invasion-Canada Episode Special Guest: Luc Nicole-Labrie is involved in heritage interpretation and preservation since 2001. Having studied history, tourism management and heritage interpretation in university, he brings a unique perspective in the field as someone who has experience as a field interpreter, as a guide, as a supervisor, as a manager and as a historian. Working at the National Battlefields Commission (Québec City, Canada) since 2007, he now acts as the Senior History Advisor for the organization. He helped create numerous exhibitions, interpretive activities, and lectures. This episode uses materials from: Cloudbank by Podington Bear (Attribution-NonCommercial 3.0 Unported) Psychic by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk) Curious Nature by Dominic Giam of Ketsa Music (licensed under a commercial non-exclusive license by the Massachusetts Historical Society through Ketsa.uk)
Older adults consist of approximately half of the patients in the ICU, with that number expected to grow in the coming decades. In this episode of the Society of Critical Care Medicine (SCCM) Podcast, host Marilyn N. Bulloch, PharmD, BCPS, FCCM, is joined by Bram Rochwerg, MD, MSc(Epi), FRCPC, FCCM, and Lauren E. Ferrante, MD, MHS, to discusses new guidelines on caring for older adults in the ICU and the difficulties in finding research that focuses on those patients. The guidelines, “Society of Critical Care Medicine Guidelines on Caring for Older Adults in the ICU,” will be published in an upcoming issue of Critical Care Medicine. The panel details the process and methodology behind the guidelines, the dearth of studies focusing on older patients in the ICU, and the difficulty of finding studies that enroll older adults who are on multiple medications. The guidelines offer two conditional recommendations and offer priorities for aging-friendly research topics to help provide stronger guidance in the future. Bram Rochwerg, MD, MSc(Epi), FRCPC, FCCM, is an associate professor, intensivist, and researcher based at McMaster University in Hamilton, Ontario, Canada, who focuses on intravenous fluid use in sepsis, the role of corticosteroids in acute hypoxemic respiratory failure, and clinical practice guideline methodology. Lauren E. Ferrante, MD, MHS, is an associate professor of medicine in the section of pulmonary, critical care, and sleep medicine at the Yale School of Medicine; director of the operations core of the Yale Claude D. Pepper Older Americans Independence Center; and an attending physician in the medical intensive care unit at Yale-New Haven Hospital in New Haven, Connecticut, USA. Resources referenced in this podcast: Society of Critical Care Medicine Guidelines on Caring for Older Adults in the ICU Compassionate and Evidence-Based Care (session from the 2026 Critical Care Congress) Congress Digital Geriatric Knowledge Education Group Thought Leader: Why the 4Ms Approach to Critical Care Improves Quality (session from the 2025 Critical Care Congress)
Welcome back to Morgan Hasn't Seen with Jeannine Brice & Morgan Robinson!!Battling extraterrestrial forces and defending planet earth on MHS throughout May as Jeannine has curated a fascinating variety of ALIEN INVASION movies for this series!A far sillier twist in the alien invasion series as we get into the realm of SNL movies with the bizarre, yet potentially poignant immigration and assimilation story in CONEHEADS (1993) starring Dan Aykroyd, Jane Curtin, and a plethora of SNL faces!Our YouTube Channel for all our regular videos: https://www.youtube.com/channel/UCvACMX8jX1qQ5ClrGW53vowDonate: https://www.buymeacoffee.com/ItsAWonderful1Join our Patreon: https://www.patreon.com/ItsAWonderful1IT'S A WONDERFUL PODCAST STORE: https://www.teepublic.com/user/g9designSub to the feed and download now on all major podcast platforms and be sure to rate, review and SHARE AROUND!!Keep up with us on (X) Twitter:Podcast: https://twitter.com/ItsAWonderful1Morgan: https://twitter.com/Th3PurpleDonJeannine: https://twitter.com/JeannineDaBean_Keep being wonderful!!
Dr. Howard Sesso of Harvard explains the results of the COSMOS trial, identifying who actually benefits from a daily multivitamin and how it impacts biological aging.Is a daily multivitamin a life-extending "insurance policy" or just a waste of money? In this clip, Dr. Howard Sesso, Co-Principal Investigator of the landmark COSMOS trial, breaks down the clinical evidence from over 21,000 participants. We explore the "sweet spot" of nutritional insufficiency; where you aren't clinically deficient but lack the levels needed for optimal healthspan.Dr. Sesso and Dr. Sidong Li discuss how multivitamins specifically slowed the "epigenetic clock" in individuals with existing risk factors like hypertension and accelerated biological aging. We also cover the importance of "precision nutrition" and why the synergy of essential vitamins and minerals may be more effective than high-dose single supplements. If you're looking for a common-sense, evidence-based approach to basic supplementation, this deep dive into the Harvard-led COSMOS data provides the answers you need.
This week on the KORE Women podcast, Dr. Summer Watson is joined by Sharon Schanzer, who is the founder of RLDGROUP, her long-running design studio, and What's Your Boulder. She is a strategic execution advisor, who helps leaders finally move the things that have been sitting in the background for far too long. Sharon challenges the common belief that we don't move forward, because we lack time, but instead shows how friction, overthinking, unclear communication, and unnecessary complexity are often the real barriers. In this conversation, we talk about how to identify the one thing that's actually holding you back, how to simplify execution, and how leaders unintentionally become bottlenecks in their own organizations. If you have something that's been sitting on your list for months or even years, this episode will give you a new way to approach it and finally move it forward. You can connect with Sharon Schanzer on LinkedIn and at: https://whatsyourboulder.com Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #ExecutionStrategy #Productivity #BusinessStrategy
Welcome back to Morgan Hasn't Seen with Jeannine Brice & Morgan Robinson!!Battling extraterrestrial forces and defending planet earth on MHS throughout May as Jeannine has curated a fascinating variety of ALIEN INVASION movies for this series!Starting things off with one of the smartest, and most unique psychological sci-fi horror movies of recent years as a guilt and anxiety-ridden Kaitlyn Dever is forced to deal with an alien home invasion, prompting her to overcome past trauma in Brain Duffield's dialogueless NO ONE WILL SAVE YOU (2023)!Our YouTube Channel for all our regular videos: https://www.youtube.com/channel/UCvACMX8jX1qQ5ClrGW53vowDonate: https://www.buymeacoffee.com/ItsAWonderful1Join our Patreon: https://www.patreon.com/ItsAWonderful1IT'S A WONDERFUL PODCAST STORE: https://www.teepublic.com/user/g9designSub to the feed and download now on all major podcast platforms and be sure to rate, review and SHARE AROUND!!Keep up with us on (X) Twitter:Podcast: https://twitter.com/ItsAWonderful1Morgan: https://twitter.com/Th3PurpleDonJeannine: https://twitter.com/JeannineDaBean_Keep being wonderful!!
This week on The KORE Women podcast, Dr. Summer Watson welcomes Dr. Courtney Beck, where they engage in a powerful conversation about living fearlessly, forging your own path, and building community that lifts others as it rises. Dr. Beck is a former NCAA All-American gymnast turned educator, podcast host, and founder of Plenty of Positivity. Dr. Beck brings a rare blend of drive and groundedness to everything she does. In this episode, she shares lessons from sport that shaped her leadership style, how she helps students and peers find their voice, and why positivity isn't just a mood, it's a movement. If you're looking for real talk about purpose, perseverance, and passing the torch, this one's for you. You can connect with Dr. Courtney Beck on LinkedIn and follow her podcast on YouTube which is called, Plenty of Positivity and check out her website at: www.plentyofpositivity.com www.plentyofpositivity.com https://www.youtube.com/@plentyofpositivity Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #PlentyOfPositivity #FearlessLeadership #WomenInSports
In this first installment of a two-part conversation, host Emma Sellers, MS, is joined by Lucy Kibe, DrPH, MS, MHS, PA-C, co-founder of AmKeny, a nonprofit that partners U.S. PAs and other clinicians with Kenyan clinical officers to support patient care, education, and community health initiatives in Kenya. She is joined by Laye Akinloye, PA-C, Emeritus; Alabi Akinloye, PA; Miriam Ha, PA; Gaelen Waar, Pre-PA Student; and Ajana Williams, Pre-PA Student, who share their experiences participating in AmKeny's medical outreach efforts. Dr. Kibe reflects on how the organization grew from a 2011 Drexel PA student trip into a sustained nonprofit focused on collaboration, cultural exchange, educational support, and strengthening local clinical officer programs. The group discusses the realities of delivering care in resource-limited settings, adapting to supply constraints, and supporting clinics focused on women's health, children's care, men's health, eye screenings, and patient intake. They also provide an inside look at AMKENY's large-scale community “medical camp,” which brings together Kenyan volunteers and U.S. clinicians to offer primary care, cervical cancer screening and treatment, dental care, counseling, spiritual support, nutrition services, physical therapy, pharmacy services, and referrals for cataract surgery. This episode is sponsored by AMBOSS. The PA Path Podcast is produced by Association Briefings.
Senescent cells — cells that have stopped dividing but refuse to die — accumulate with age and are increasingly recognised as a key driver of age-related disease. Most people in the longevity space are familiar with senolytics like dasatinib and quercetin, but a potentially more precise approach is emerging: harnessing the immune system itself to find and eliminate senescent cells.Dr. Amit Sharma leads the senescence immunology group at the Lifespan Research Institute, where his lab studies how natural killer cells and gamma delta T cells interact with senescent cells — and how that relationship breaks down with age. In this conversation, we explore the biology of immune surveillance of senescence, why it fails as we get older, and what his lab is doing to restore and enhance it. We also discuss the iron-ferroptosis connection, next-generation senolytics, and what the next decade might bring for senotherapy.
This week on the KORE Women podcast, Dr. Summer Watson is joined by Ell Graniel, who is a neuroscience-based strategist, author, and founder of Truespeak, who brings a powerful and practical perspective on how our brains shape the way we think, decide, and show up in the world. In this conversation, we talk about why we second-guess ourselves, how our internal language influences our outcomes, and why the idea that we all have the same 24 hours in a day may not be true. Ell shares how understanding the brain at a deeper level can help us move out of overthinking, release unnecessary pressure, and create new patterns that lead to clarity and action. If you've ever felt stuck in indecision, overwhelmed by time, or frustrated by your own thinking patterns, this episode will give you a completely different lens. You can connect with Ell Graniel on LinkedIn, on YouTube at: TrueSpeak featuring Ell Graniel, on Instagram at: TrueSpeak.US and at: EllGraniel.com Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #TheKOREWomenPodcast #Neuroscience #BrainBasedLeadership #Neuroplasticity
Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS. Related Content: Cardiac Resynchronization Therapy Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure
Longevity researcher Nir Barzilai on what centenarians reveal about aging and the four drugs scientists believe may target it directly.Dr Nir Barzilai has spent decades studying people who live to 100 and beyond. What he's found challenges many assumptions about aging, disease, and what we can actually do about them. In this conversation we cover what centenarian research really shows, including why they get the same diseases as the rest of us, just decades later, and what that means for the goal of longevity medicine. We then move into the practical territory: what criteria distinguish a drug that treats one disease from one that may target aging itself, which four currently approved drugs score highest on that framework, and how leading longevity physicians are beginning to use them in practice. We also discuss GLP-1 agonists in depth; their mechanisms, the emerging evidence for benefits well beyond weight loss, and the important caveats around muscle loss. Essential viewing for anyone following the science of healthy aging.
4-24-26 PHS 10-MHS 3 by MBC Grand, Inc.
GLP-1 drugs likesemaglutide and ozempic have become household names but how much do we reallyunderstand about what they're doing inside the body? In this episode I sit downwith Dr. Mikhail Kolonin, Professor and Director of the Center for Metabolicand Degenerative Diseases at UTHealth Houston's McGovern Medical School, whoselab has spent years uncovering the deeper biology of these drugs.We go far beyondweight loss. Dr. Kolonin explains how GLP-1 drugs trigger IL-6 signaling in fattissue, activating a thermogenic program that converts metabolically inactivewhite fat into energy-burning brown fat and how in some patients this isaccompanied by upregulation of telomerase, a protein with profound implicationsfor mitochondrial health and aging. We also tackle the muscle loss questiondirectly, examining what the latest research reveals about why lean mass losson GLP-1s exceeds simple caloric restriction, and what can realistically bedone about it.
4-21-26 PHS 12-MHS 2 by MBC Grand, Inc.
This week on The KORE Women podcast, Dr. Summer Watson welcomes Theresa Lear Levine, EFT, who is a Master Practitioner, hypnotherapist, International Bestselling Author of “Becoming More Me,” developer of the "Becoming More You" Coaching Program that supports “busy-minded Entrepreneurs & Professionals through Transcending Trauma, Distraction and Overwhelm, so they can Double their Income, Reclaim their personal power, Connect deeper in their relationships, and become more present and purpose-driven on their journey of Becoming.” She is also the host of the Becoming More Me podcast. During this episode, we explore how subconscious rewiring, emotional freedom techniques, and nervous system healing can shift you from hustle and grind into pleasure-fueled achievement and true self-trust. If you've ever wondered why you still feel stuck despite working so hard, this conversation will open your eyes and give you a new path forward. You can connect with Theresa Lear Levine on Instagram, YouTube, and at: TheresaLearLevine.com Instagram: @theresalearlevine YouTube: youtube.com/@theresalearlevine Website: theresalearlevine.com Find her book “Becoming More Me” on Amazon. Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomen #NervousSystemHealing #TraumaHealing #EmotionalFreedomTechnique
Interview with Vineet Ahuja, DM, author of Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Trial and Michael H. Woodworth, MD, MSc, author of Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? Hosted by Ilana Richman, MD, MHS. Related Content: Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption?
Interview with Vineet Ahuja, DM, author of Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Trial and Michael H. Woodworth, MD, MSc, author of Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? Hosted by Ilana Richman, MD, MHS. Related Content: Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption?
In this special “Ask the Expert” collaboration between The MOG Project and SRNA, Julia Lefelar and Dr. GG deFiebre welcomed Dr. Benjamin Greenberg of UT Southwestern, who answered questions from the audience. Dr. Greenberg reviewed major advances in MOG antibody disease research and diagnostic criteria [00:05:06]. He discussed efforts to predict relapse risk using sustained antibody positivity, demographic and clinical models, and immune-cell profiling studies [00:07:55]. Dr. Greenberg detailed controversies around low-positive antibody titers and how cell-based assays and dilution thresholds affect specificity [00:21:38]. He outlined concepts and progress in tolerance-inducing approaches such as Tregs and CAR T therapy, described differences from B-cell–depleting drugs like rituximab [00:26:32] Finally, Dr. Greenberg highlighted the satralizumab meteoroid trial and the ongoing cosMOG study of rozanolixizumab, emphasizing community engagement, registries, surveys, and trial participation to accelerate access and potential curative strategies [00:38:36]. You can learn more about The MOG Project here:https://mogproject.org/Benjamin M. Greenberg, MD, MHS is a Professor and the Cain Denius Scholar in Mobility Disorders in the Department of Neurology [ https://utswmed.org/why-utsw/departments/neurology/ ] at UT Southwestern Medical Center in Dallas, Texas. He currently serves as the Vice Chair of Translational Research and Strategic Initiatives for the Department of Neurology. He is also the interim Director of the Multiple Sclerosis Center [ https://utswmed.org/locations/aston/multiple-sclerosis-and-neuroimmunology-clinic/ ] and the Director of the Neurosciences Clinical Research Center. In addition, he serves as Director of the Transverse Myelitis and Neuromyelitis Optica Program and the Pediatric Demyelinating Disease Program at Children's Medical Center [ https://www.childrens.com/specialties-services/specialty-centers-and-programs/neurology/demyelinating-disease-program ].Dr. Greenberg earned his medical degree at Baylor College of Medicine before completing an internal medicine internship at Chicago's Rush Presbyterian-St. Luke's Medical Center. He performed his neurology residency at the Johns Hopkins School of Medicine. He also holds an M.H.S. in molecular microbiology and immunology from the Bloomberg School of Public Health, as well as a bachelor's degree in the history of medicine – both from Johns Hopkins. Prior to his recruitment to UT Southwestern in 2009, Dr. Greenberg was on the faculty of the Johns Hopkins Division of Neuroimmunology, serving as the Director of the Encephalitis Center and Co-Director of the nation's first dedicated Transverse Myelitis Center.Dr. Greenberg splits his clinical time between adult and pediatric patients at William P. Clements Jr. and Zale Lipshy University Hospitals, Parkland, and Children's Medical Center. His research focuses on better diagnosing, prognosticating, and treating demyelinating diseases and nervous system infections. He also coordinates clinical trials to evaluate new treatments to prevent neurologic damage and restore function to affected patients.00:00 Welcome01:44 Hosts and Guest Intro05:06 Research Buckets Overview07:55 Predicting Relapse Risk11:46 Tregs and Immune Brakes17:40 Attack Severity and Relapse19:24 MOGAD Criteria Updates21:38 Titers Explained Simply26:32 Targeting MOG Antibodies29:11 CAR T and Immune Reset32:39 When Criteria Changes33:52 Tolerance Research Boom34:48 From Animals to Trials37:17 Community Drives Progress38:36 Meteoroid and cosMOG Clinical Trials41:39 How These Drugs Work44:02 FDA Approval and Access45:49 Insurance Switch Concerns48:39 Rituximab Dosing Debate52:41 Why Antibodies Develop54:18 Future Attack Patterns55:47 CAR T Versus Rituximab57:10 Lab Research and Support01:00:51 Hope for a Cure01:02:14 Closing and Resources
This week on the KORE Women podcast, Dr. Summer Watson is joined by Jaclyn Beattie, who is a custom menswear designer, wardrobe strategist, and trusted image advisor to CEOs, attorneys, executives, and high-level leaders. Jaclyn's approach is practical and powerful and style isn't about vanity, it's about vision. In this episode, she shares how decision fatigue drains our leadership energy and how a simplified, intentional wardrobe can boost confidence, presence, and performance. If you want to look the part without wasting time, overthinking your outfits, or chasing trends, this is the strategy session you need. You can connect with Jaclyn Beattie on LinkedIn and at: www.jaclynbeattie.com Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #StyleStrategy #ExecutivePresence #HighPerformerStyle
Dr. Anurag Singh, Chief Scientific Officer at Timeline Nutrition joins Modern Healthspan for an in-depth conversation about urolithin A and the science of mitophagy, the cellular process that cleans out damaged mitochondria.We explore the clinical evidence from multiple human trials: the ATLAS trial showing 12% muscle strength gains and 10% VO2 max improvements in sedentary middle-aged adults, independent studies in elite athletes demonstrating enhanced recovery and performance, and the groundbreaking MitoImmune trial published in Nature Aging revealing 20% increases in immune cell mitochondria in just 28 days.Dr. Singh provides practical guidance on dosing (500mg vs 1000mg), timing, and who benefits most from supplementation. We discuss why only 30% of people can produce urolithin A naturally from foods like pomegranates and berries, and how direct supplementation overcomes this limitation.Looking ahead, we cover Timeline's Healthspan XPrize semi-finalist status, ongoing blood-brain barrier research setting the stage for brain health trials, and Dr. Singh's vision for combining mitophagy activation with emerging therapies like mitochondrial transplantation. He also shares why he believes mitochondrial dysfunction is "the mother of all hallmarks of aging."Whether you're interested in the science of healthy aging, considering urolithin A supplementation, or want to understand the future of longevity medicine, this comprehensive conversation provides the evidence and insights you need.Topics covered:• What urolithin A is and how mitophagy works• ATLAS trial results: muscle, endurance, and inflammation• MitoImmune trial: immune system rejuvenation• Practical supplementation guide• Brain health research and future directions• The role of mitochondrial health in aging
Please visit answersincme.com/860/102620367-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Keith C. Ferdinand, MD; and Henry J. Michtalik, MD, MPH, MHS. IIn this activity, experts in preventive cardiology and hospital medicine discuss secondary stroke prevention strategies for hospitalists and internists. Upon completion of this activity, participants should be better able to: Evaluate guideline-recommended secondary stroke prevention strategies after ischemic stroke or TIA; Describe the clinical rationale for FXIa inhibitors; Discuss the clinical significance of the latest efficacy and safety data for FXIa inhibitors in secondary stroke prevention; and Apply best practices for transitioning patients from inpatient to outpatient secondary stroke prevention care.
This week on the KORE Women podcast, Dr. Summer Watson is joined by Val Roskens Tews, who is a content strategy writer and author. Val reminds us that visibility online doesn't have to be loud or overwhelming. Val believes in the quiet power of kindness and the ripple effect created when we show up with thoughtful conversations, meaningful engagement, and authentic content. Through her “Butterfly Strategy,” she helps people, who have spent years supporting others to feel confident sharing their own voice. In this episode, we talk about why so many people struggle to talk about themselves online, how small actions can create real opportunities, and how building a community of business friends and collaborators can transform the way we experience social media. If you've ever felt hesitant about posting or unsure how to show up online, this conversation will give you a refreshing perspective. You can connect with Val Roskens Tews on LinkedIn and at: butterflycopywriting.com/ and at: valroskenstews.com Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Thank you for listening! Please share this podcast with your family and friends. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #ContentStrategy #OnlineVisibility #MeaningfulConnections
Explore evidence-based clinical signs, diagnostic accuracy, and practical assessment strategies to optimize care with an in-depth look at the latest information on pediatric concussion. JAMA Review author Sonal N. Shah, MD, MPH, of Boston Children's Hospital, discusses this and more with JAMA Associate Editor David Simel, MD, MHS. Related Content: Does This Child Have a Concussion? Even Mild Concussions Tied to Worse Cognition Later in Life Vestibular/Ocular Motor Screening (VOMS) in Suspected Concussion Balance and Gait Assessment Including Modified BESS Cervical Spine Examination in Suspected Concussion
Today we are talking to Liza Rankow about some things that just might hold the power to change the world. Liza J. Rankow, PhD, MHS, is an interfaith minister, educator, activist, and author. Her lifework centers the deep healing that is essential to personal and social transformation. Liza is the founder and former executive director of OneLife Institute, which for almost 20 years supported the well-being of frontline changemakers. She has been a spiritual counselor and teacher for more than three decades, working with individual clients, facilitating healing retreats, and offering classes and workshops in a variety of community and academic settings. Liza is the producer and co-editor of The Living Wisdom of Howard Thurman audio collection. Her new book is Soul Medicine for a Fractured World: Healing, Justice, and the Path of Wholeness and she's joining us today to talk a bit about it. Enjoy! SHOW NOTES: LIZA RANKOW: https://www.lizarankow.org SOUL MEDICINE FOR A FRACTURED WORLD: https://amzn.to/3Qc4RAP MY NEW BOOK: https://a.co/d/fsUTllj ART STUDIO: https://www.whatifproject.net/art EBAY ART: https://www.ebay.com/usr/what_if_project SUPPORT THE SHOW: https://www.whatifproject.net/support (**NOTE: these show notes contain Amazon affiliate links. If you use these links to buy something I may earn a small commission)
Dr. Mike Studer, PT, DPT, MHS,NCS, CEEAA, CWT, CSST, CBFP, CSRP, FAPTA is a nationally and internationally recognized expert in neurologic physical therapy, aging, and brain health. With over three decades of experience, Mike has spoken in all 50 states and across six continents, bringing a powerful blend of science, motivation, and real-world application to rehabilitation and performance. He's a board-certified neurologic PT, educator, researcher, and co-founder of Spark Rehabilitation and Wellness in Bend, Oregon. Mike is also the only physical therapist in the U.S. to be named Clinician of the Year by both the Neurologic and Geriatric Academies and is a Catherine Worthingham Fellow, one of the profession's highest honors. Beyond his clinical and academic impact, he's an author, consultant to elite athletes, and even a world-record holder for the fastest underwater treadmill marathon, a mark that was set most recently in January 2022. His work centers on helping people extend not just lifespan, but healthspan, with purpose and vitality.Send us Fan Mail
This week on The KORE Women podcast, Dr. Summer Watson welcomes Dr. Janice Gassam Asare, who is an organizational psychologist, Forbes contributor, TEDx speaker, and author of the upcoming book, “Rise and Resist: How to Reclaim Workplace Equity and Justice.” They dig into why traditional DEI efforts often fail the people they're meant to help, how to navigate equity pushback in a time of rollbacks, and what real empowerment looks like in today's workplace. Dr. Asare brings both heart and hard truth, offering a fresh perspective on what it means to lead change with clarity, courage, and care. If you're ready to move beyond performative inclusion and into transformative action, this episode is for you. You can connect with Dr. Janice Z. Gassam Asare on LinkedIn and Instagram. LinkedIn: https://www.linkedin.com/in/janicegassamphd/ Instagram: https://instagram.com/janicejnice Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. Disclaimer: Each guest shares their own experiences and perspectives and is responsible for the accuracy of the statements they make, whether in the episode or in related content. #KOREWomenPodcast #RiseAndResist #WorkplaceEquity #EquityInAction
This week on The KORE Women podcast, Dr. Summer Watson welcomes Candice Snyder, a Gratitude Ambassador and Mental Health Advocate, who talks about what happens when life keeps throwing curveballs, such as job loss, divorce, miscarriage, and unimaginable grief and how you can still decide to build something beautiful? As the host of the globally ranked Passion Purpose and Possibilities podcast and Author, she has turned personal adversity into global impact, where she shares stories that inspire, heal, and activate. This episode is a heartfelt look at: finding gratitude in the darkest seasons, advocating for mental health through storytelling, and discovering your voice, even when it shakes. Tune in and learn how purpose is often born from the messiest chapters of our lives. You can connect with Candice Snyder on: Facebook, LinkedIn, in her FB group: Passion Purpose and Possibilities Podcast Community Group, on Instagram at: passionpurposepossibilities and her podcast Passion, Purpose and Possibilities. Follow the podcast at: https://www.podpage.com/passion-purpose-and-possibilities-1/ Thank you for taking the time to listen to the KORE Women podcast and being a part of the KORE Women experience. You can listen to The KORE Women podcast on your favorite podcast directory - Pandora, iHeartRadio, Apple Podcast, Google Podcast, YouTube, Spotify, Stitcher, Podbean, JioSaavn, Amazon and at: www.KOREWomen.com/podcast. Please leave your comments and reviews about the podcast and check out KORE Women on Instagram, Twitter, and Facebook. You can also learn more about Dr. Summer Watson, MHS, PhD, KORE Women, LLC, the KORE Women podcast, KORE Business Solutions (a Virtual Assistant service) and Cross-Generational Consultation Services by going to: www.korewomen.com. #KOREWomenPodcast #PurposeDriven #ResilienceStory #WomenWhoInspire
Resistant hypertension affects about 10% of those treated for hypertension. Managing it involves lowering sodium intake, exercising, losing weight, reducing alcohol consumption, and using optimal diuretics, combination pills, and mineralocorticoid antagonists. Author Michel Azizi, MD, PhD, from Hospital European Georges Pompidou in France discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content: Diagnosis and Management of Resistant Hypertension
Giulia Heyward, WNYC and Gothamist reporter, talks about the tug of war between the state and the federal government over transgender care for those 19 and younger. Then, Jack Turban MD, MHS, adult, child, and adolescent psychiatrist and author of Free to Be: Understanding Kids & Gender Identity (Atria Books, 2024), offers best practices for transgender care for those 19 and younger. Photo: Dusk view of entrance to new Children's Hospital at NYU Langone, New York - stock photo. Credit: Barry Winiker, Getty Images.
In this episode, Anik Patel, MD, FAAP, discusses the effects of armed conflict on children and adolescents. David Hill, MD, FAAP, and Joanna Parga-Belinkie, MD, FAAP, also speak with Katie Piwnica-Worms, MD, MHS, about short-term Medicaid utilization associated with an advanced primary care model. For resources go to aap.org/podcast.